Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells-Reference-Cited by-同舟云学术

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells

Published:2017-08-14 Issue:1 Volume:9 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Li Yin,Wang Yan,Zhou Yong,Li Jie,Chen Kai,Zhang Leisi,Deng Manman,Deng Suqi,Li Peng,Xu Bing

Funder

National Natural Science Foundation of China

The Guangdong Provincial Basic Research Program, PR China

Science and Technology Program of Guangzhou, PR China

Medical Innovation Program of Fujian Province, PR China

Guangdong Provincial Applied Science and Technology Research Development Program

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-017-0377-8.pdf

Reference25 articles.

1. Crisanti MC, Wallace AF, Kapoor V, Vandermeers F, Dowling ML, Pereira LP, et al. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther. 2009;8(8):2221–31. doi: 10.1158/1535-7163.MCT-09-0138 .

2. Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression. Cancer Res. 2009;69(21):8403–11. doi: 10.1158/0008-5472.CAN-09-2146 .

3. Ogawa Y, Ogura M, Tobinai K, Ando K, Suzuki T, Watanabe T, et al. A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myeloma. Int J Hematol. 2016;103(1):25–33. doi: 10.1007/s12185-015-1897-7 .

4. Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous t-cell lymphoma (CTCL). Blood. 2007;109(1):31–9. doi: 10.1182/blood-2006-06-025999 .

5. Jin Y, Yao Y, Chen L, Zhu X, Jin B, Shen Y, et al. Depletion of γ-catenin by histone deacetylase inhibition confers elimination of CML stem cells in combination with imatinib. Theranostics. 2016;6(11):1947–62. doi: 10.7150/thno.16139 .

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chidamide maintenance therapy after allo-HSCT in SET-NUP214 fusion positive T-ALL patients: A report of two cases;Transplant Immunology;2024-12

2. Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Study from a Single-Center;Current Medical Science;2023-12

3. Review of Patents for Anticancer Agents Targeting Adenosine Monophosphate-Activated Protein Kinase;Journal of Medicinal Food;2023-09-01

4. Combinations of HDAC inhibitor and PPAR agonist induce ferroptosis of leukemia stem and progenitor cells in acute myeloid leukemia;2023-08-01

5. Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression;Cancer Biology & Therapy;2023-06-28